BME:NYE-Blackrock Health Sciences Trust (USD)

ETF | Asset Management | New York Stock Exchange

Last Closing

USD 39.06

Change

+0.02 (+0.05)%

Market Cap

USD 0.29B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Under normal market conditions the Fund will invest at least 80% if its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Fund will consider a company to be principally engaged in a health science or related industry if 50% or more of its revenues are derived from, or 50% or more of its assets are related to, its health sciences business. Although the Trust generally will invest in companies included in the Russell 3000 Index, the Trust may invest in equity securities of health sciences companies with any size market capitalisation, including small and min-cap health sciences companies and companies that are not in the Russell 3000 Index. The Trust may invest up to 20% of its total assets in other investments. These investments may include equity and debt securities of companies not engaged in the health sciences industry. The Trust reserves the right to invest up to 10% of its total assets in non-investment grade debt securities.

Inception Date: 28/03/2005

Primary Benchmark: NA

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 1.13%

Management Expense Ratio:

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Asset Management

Symbol Name Mer Price(Change) Market Cap
BX Blackstone Group Inc 0.00 %

+3.23 (+2.70%)

USD 154.61B
BLK BlackRock Inc 0.00 %

+10.80 (+1.39%)

USD 115.66B
KKR KKR & Co LP 0.00 %

+2.55 (+2.56%)

USD 89.77B
IVSXF Investor AB (publ) 0.00 %

N/A

USD 74.08B
IVSBF Investor AB ser. B 0.00 %

-0.10 (-0.38%)

USD 74.08B
BN Brookfield Corp 0.00 %

+0.26 (+0.59%)

USD 66.64B
APO Apollo Global Management LLC C.. 0.00 %

-1.13 (-1.00%)

USD 64.48B
BK Bank of New York Mellon 0.00 %

+0.84 (+1.46%)

USD 43.01B
ARES Ares Management LP 0.00 %

+3.77 (+2.72%)

USD 42.95B
AMP Ameriprise Financial Inc 0.00 %

+4.09 (+0.96%)

USD 42.31B

ETFs Containing BME

F4DE:XETRA Ossiam Food for Biodivers.. 4.07 % 0.00 %

+0.24 (+0.00%)

USD 0.04B
F4DU:XETRA Ossiam Food for Biodivers.. 4.07 % 0.00 %

+0.43 (+0.00%)

USD 7.14M
CSUKS:SW iShares VII PLC - iShares.. 1.75 % 0.00 %

N/A

USD 0.18B
SMCX:SW SPDR® MSCI Europe Small .. 0.52 % 0.00 %

N/A

USD 0.22B
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.27 (+0.00%)

USD 0.11B
SCID 0.00 % 0.39 %

N/A

N/A
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+0.51 (+0.00%)

USD 9.21B
CUKS:LSE iShares VII PLC - iShares.. 0.00 % 0.00 %

+117.50 (+0.00%)

USD 0.17B
UKMV:LSE 0.00 % 0.00 %

N/A

N/A
XXSC:LSE db x-trackers MSCI Europe.. 0.00 % 0.00 %

+21.00 (+0.00%)

USD 1.10B
SMC:PA SPDR MSCI Europe Small Ca.. 0.00 % 0.00 %

+1.20 (+0.00%)

USD 0.22B
DX2J:F Xtrackers MSCI Europe Sma.. 0.00 % 0.00 %

N/A

USD 1.34B
EXH8:F iShares (DE) I - iShares .. 0.00 % 0.00 %

-0.14 (0.00%)

USD 0.01B
SXRD:F iShares VII Public Limite.. 0.00 % 0.00 %

+1.35 (+0.00%)

USD 0.18B
DX2J:XETRA Xtrackers MSCI Europe Sma.. 0.00 % 0.00 %

+0.14 (+0.00%)

USD 0.78B
EXH8:XETRA iShares (DE) I - iShares .. 0.00 % 0.00 %

-0.21 (0.00%)

USD 0.01B
SXRD:XETRA iShares VII PLC - iShares.. 0.00 % 0.00 %

+1.30 (+0.00%)

USD 0.18B

Market Performance

  Market Performance vs. Industry/Classification (Asset Management) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.46% 21% F 29% F
Dividend Return 2.11% 49% F 80% B-
Total Return -1.35% 24% F 32% F
Trailing 12 Months  
Capital Gain -9.01% 11% F 20% F
Dividend Return 4.96% 42% F 68% D+
Total Return -4.05% 11% F 21% F
Trailing 5 Years  
Capital Gain 3.61% 88% B+ 50% F
Dividend Return 31.24% 52% F 87% B+
Total Return 34.85% 82% B 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 1.37% 79% B- 46% F
Dividend Return 6.95% 74% C 57% F
Total Return 5.58% 48% F 85% B
Risk Return Profile  
Volatility (Standard Deviation) 12.18% 80% B- 76% C+
Risk Adjusted Return 57.06% 94% A 81% B-
Market Capitalization 0.29B 68% D+ 47% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector